| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 64.89% | 65.35% | 36.53% | 3.45% | 7 | -27.10% | 2025-06-23 |
| 2 | 刘浩 | 华创证券 | 医药生物 | 64.84% | 65.65% | 14.01% | 20.00% | 2 | -47.33% | 2025-07-02 |
| 3 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 64.40% | 59.45% | 30.44% | 3.45% | 7 | -27.10% | 2025-06-20 |
| 4 | 刘浩 | 华创证券 | 医药生物 | 64.19% | 62.71% | 29.38% | 20.00% | 2 | -47.33% | 2025-06-30 |
| 5 | 刘浩 | 华创证券 | 医药生物 | 64.06% | 50.92% | 35.71% | 20.00% | 2 | -47.33% | 2025-06-05 |
| 6 | 李安飞 | 广发证券 | 医药生物 | 63.97% | 50.60% | 36.68% | 2.86% | 1 | -56.96% | 2025-06-10 |
| 7 | 刘浩 | 华创证券 | 医药生物 | 63.86% | 68.91% | 27.60% | 20.00% | 2 | -47.33% | 2025-07-08 |
| 8 | 刘浩 | 华创证券 | 医药生物 | 63.86% | 67.97% | 36.45% | 20.00% | 2 | -47.33% | 2025-07-07 |
| 9 | 唐寅灏 | 中信证券 | 医药生物 | 63.65% | 70.87% | 37.65% | 60.00% | 13 | -8.47% | 2025-07-15 |
| 10 | 刘浩 | 华创证券 | 医药生物 | 62.65% | 51.53% | 39.04% | 20.00% | 2 | -47.33% | 2025-05-30 |
| 11 | 刘浩 | 华创证券 | 医药生物 | 62.39% | 56.67% | 32.91% | 20.00% | 2 | -47.33% | 2025-06-17 |
| 12 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 62.20% | 61.06% | 43.23% | 3.45% | 6 | -27.10% | 2025-05-28 |
| 13 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 62.09% | 67.15% | 41.84% | 3.45% | 6 | -27.10% | 2025-05-23 |
| 14 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 61.95% | 60.39% | 37.07% | 3.45% | 6 | -27.10% | 2025-05-27 |
| 15 | 李安飞 | 广发证券 | 医药生物 | 61.45% | 50.94% | 34.92% | 2.86% | 1 | -56.96% | 2025-06-11 |
| 16 | 阳景 | 浦银国际证券 | 医药生物 | 61.08% | 55.43% | 30.72% | 100.00% | 3 | 0.00% | 2025-07-28 |
| 17 | 刘浩 | 华创证券 | 医药生物 | 60.74% | 62.42% | 38.66% | 20.00% | 2 | -47.33% | 2025-06-25 |
| 18 | 刘浩 | 华创证券 | 医药生物 | 60.45% | 57.07% | 28.38% | 20.00% | 2 | -47.33% | 2025-06-19 |
| 19 | 唐寅灏 | 中信证券 | 医药生物 | 60.38% | 65.26% | 31.77% | 60.00% | 13 | -8.47% | 2025-07-14 |
| 20 | 阳景 | 浦银国际证券 | 医药生物 | 59.99% | 54.38% | 26.82% | 100.00% | 3 | 0.00% | 2025-08-01 |